ProShares Nanotechnology ETF (ARCA: TINY)

Ultime notizie per ProShares Nanotechnology ETF (ARCA:TINY)

Harris & Harris Group, Inc.

NASDAQ

Technology

Healthcare

Other

Basic Materials

The Fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the Index. The Index is designed to measure the performance of companies that have business operations in the field of nanotechnology. The index provider uses a natural language processing algorithm to identify companies that fall into one or more of the following categories AS (1) production of nanotechnology, which can be defined as the use of matter on an atomic and molecular level, (2) active in the fields of nanomedicine, nanomaterials, nanoelectronics, nanometrology or molecular nanotechnology, and (3) development of technologies that promote advances in or research related to nanotechnologies.

NVIDIA Corporation

Tower Semiconductor Ltd

Axcelis Technologies Inc

Taiwan Semiconductor - Adr

Canon Inc

Kla Corp

Applied Materials, Inc.

Agilent Technologies Inc

Onto Innovation Inc

Ordinary Shares

Lam Research Corp

Asml Holding Nv

Taiwan Semiconductor-Sp Adr

Brukercorp.

Entegris, Inc.

Intel Corp

Proshares Nanotechnology ETF

ProShares Nanotechnology ETF

Tiny Ltd

TINYBEANS GROUP PTY LTD by Tinybeans Group Ltd

Tinybeans Group Ltd

Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) shares are trading lower on Friday following the announcement of the sale of its manufacturing <a href="https://www.benzinga.com/pressreleases/24/09/g41065724/coherent-announces-sale-of-uk-manufacturing-facility-following-strategic-review" target="_blank" rel="noreferrer noopener">facility in Newton Aycliffe, County Durham, U.K.</a>
This sale is part of the company&#8217;s strategy to streamline operations and optimize its global footprint.
The 310,000-square-foot facility, located in Aycliffe Business Park, was acquired by the former II VI Incorporated (now Coherent Corp.) in 2017. Macquarie Semiconductor and Technology, a unit of Macquarie Group&#8217;s Commodities and Global Markets division, served as the transaction consultant, while Taylor Wessing provided legal advice to Coherent.
According to&nbsp;<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>, Coherent stock has gained over 183% in the past year.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40414154/coherent-analysts-increase-their-forecasts-after-upbeat-earnings" rel="noreferrer noopener">Coherent Analysts Increase Their Forecasts After Upbeat Earnings</a>
Investors can gain exposure to the stock via&nbsp;ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>) and&nbsp;Professionally Managed Portfolios Otter Creek Focus Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OCFS#NYSE">OCFS</a>).
On Thursday, the company announced the launch today of its 200 mm silicon carbide <a href="https://www.benzinga.com/pressreleases/24/09/g41056528/coherent-expands-silicon-carbide-200-mm-n-type-epitaxial-wafer-production" target="_blank" rel="noreferrer noopener">epitaxial wafers (SiC epi-wafers)</a>. Shipments of substrate and epi-wafers with thicknesses of 350 microns and 500 microns are now in progress.
Earlier this year,&nbsp;Coherent launched a next-generation high-power laser sensor designed to support the expanding high-power applications market and can reduce&nbsp;<a href="https://www.benzinga.com/pressreleases/24/05/g39080433/coherent-introduces-high-power-laser-sensor" target="_blank" rel="noreferrer noopener">measurement times by up to 500%</a>.
COHR Price Action: Coherent shares are trading lower by 2.63% to $89.99 at publication Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/41068397/tesla-cranks-up-the-heat-in-china-extends-5-year-0-interest-loan-offer-to-oct-31" target="_blank" rel="noreferrer noopener">Tesla Cranks Up The Heat In China, Extends 5-Year, 0% Interest Loan Offer to Oct 31</a></li>
</ul>
Photo: Shutterstock

Equities

News

Global

Markets

Movers

Tech

General

COHR

Professionally Managed Portfolios Otter Creek Focus Strategy ETF

OCFS

TINY

What's Going On With Coherent Stock Friday?

Editor&#8217;s Note: The first paragraph has been amended to correct TSMC&#8217;s stance
Monday, Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) snubbed the Wall Street journal report that claims its plans for <a href="https://www.benzinga.com/markets/equities/24/09/40973148/tsmc-and-samsung-explore-100b-chip-megafactories-in-uae-amid-ai-boom-and-global-expansion-plans-" target="_blank" rel="noreferrer noopener">new foreign investments</a> are backed by United Arab Emirates (UAE) subsidies.
Recent reports indicated the Taiwanese contract chipmaker intends to collaborate with Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) for a project in the UAE. The initiative entails investments exceeding $100 billion, the Taipei Times <a href="https://www.taipeitimes.com/News/biz/archives/2024/09/23/2003824231" target="_blank" rel="noreferrer noopener">reports</a>.
Taiwan Semiconductor executives reportedly visited the UAE and discussed a plant with advanced facilities akin to Taiwan.
Taiwan Semiconductor remains focused on its <a href="https://www.benzinga.com/government/24/09/40940463/whats-going-on-with-taiwan-semiconductor-stock-on-thursday" target="_blank" rel="noreferrer noopener">U.S. expansion</a>. It promoted Rose Castanares, executive vice president of the Arizona unit, as president last week. The company is a key supplier to Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>). The company also inked at least two smartphone chip deals. One agreement is with Apple for the iPhone and the other is with Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) for the Google Pixel 10 and Pixel 11.
Taiwan Semiconductor is building two fabs in Arizona involving the 4nm, 3nm, and 2nm processes. It also targets a third fab in Arizona, leveraging the 2nm process.&nbsp;
The U.S. offered the chipmaker a $6.6 billion federal grant and $5 billion in loans. Last week, the U.S. Federal Reserve slashed its benchmark interest rate by 50 basis points. Setting the interest rate at 4.75%-5% to spur growth can be a tailwind for capital-intensive semiconductor companies.
Taiwan Semiconductor stock has been up 102% in the last 12 months, being the critical contract chipmaker for AI chips. Investors can gain exposure to Taiwan Semiconductor through ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>) and First Trust S-Network Electric &amp; Future Vehicle Ecosystem ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARZ#NASDAQ">CARZ</a>).
Price Action: Taiwan Semiconductor stock is up 0.35% at $174.69 premarket at last check Monday.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40976900/wall-street-eyes-modestly-positive-start-as-atypical-september-rally-generates-positive-sentiment-c">Wall Street Eyes Modestly Positive Start As Atypical September Rally Generates Positive Sentiment, China Cuts Rate: Intel, Palantir, Bitcoin Make Huge Moves</a></li>
</ul>
Image: Shutterstock

Government

Regulations

Media

AAPL

CARZ

GOOG

GOOGL

NVDA

SSNLF

Taiwan Semiconductor Denies UAE Investment Rumors: Report (UPDATED)

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) has successfully fueled Japan&#8217;s record land price appreciation for the second year, reflecting the importance of the projects on the economy.
The contract chipmaker&#8217;s new chip plants on the southern island of Kyushu have been instrumental in driving up land prices by 33.3%, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-17/tsmc-plants-fuel-japan-s-biggest-land-price-rises-for-2nd-year?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">cites</a> Ministry of Land, Infrastructure, Transport and Tourism data.
<a target="_blank" href="https://www.benzinga.com/markets/equities/24/01/36821337/tsmc-reportedly-expands-in-japan-with-a-second-plant-investing-billions-and-shaping-the-future-o" rel="noreferrer noopener">Prior reports indicated</a> Taiwan Semiconductor was eying a second Japanese plant in Kumamoto, potentially investing $13.5 billion after making its debut in the country with a wafer factory worth $8.6 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/40790997/taiwan-semiconductors-strong-august-sales-hint-at-big-gains-ahead-ai-and-iphone-demand-fuel-optimism" rel="noreferrer noopener">Taiwan Semiconductor&#8217;s Strong August Sales Hint at Big Gains Ahead, AI and iPhone Demand Fuel Optimism</a>
It also plans a third advanced chipmaking plant in Japan, worth $20 billion, in Kumamoto prefecture, to produce 3-nanometer chips as Japan overhauls its chip strategy.
Taiwan Semiconductor stock has risen over 88% in the last 12 months as the Big Techs, including Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Google parent Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), remain invested in their artificial intelligence technology ambitions.
Recently Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>)-owned Samsung Foundry lost a Google smartphone deal to Taiwan Semiconductor due to <a target="_blank" href="https://www.benzinga.com/news/24/09/40833611/google-picks-taiwan-semiconductor-for-pixel-chips-samsung-loses-key-deal-report" rel="noreferrer noopener">Samsung&#8217;s outdated technology</a>.
Investors can gain exposure to Taiwan Semiconductor through SPDR S&amp;P Emerging Asia Pacific ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMF#NYSE">GMF</a>) and ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>).
Price Action: TSM stock is down 1.14% at $167.16 at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40897994/whats-going-on-with-intel-stock-on-tuesday" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Intel Stock On Tuesday?</a></li>
</ul>
Photo by Jack Hong via Shutterstock

AMZN

MSFT

Taiwan Semiconductor Fuels Japan's Land Boom With New Chip Plants: Report

Taiwan Semiconductor Manufacturing Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) topline growth was 33% in <a target="_blank" href="https://pr.tsmc.com/english/news/3171" rel="noreferrer noopener">August 2024</a>. The contract chipmaker&#8217;s sales&nbsp;reached&nbsp;NT$250.9 billion ($7.8 billion) in August 2024, implying a 2.4% sequential decline.
The year-on-year growth signaled optimism over smartphone market recovery and continued demand for&nbsp;Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) AI chips, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-10/tsmc-s-august-revenue-climbs-33-as-ai-chip-demand-holds-up?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">reports</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/40754938/semiconductor-etfs-take-a-beating-dragged-lower-by-nvidia-amd-and-broadcom-stocks" rel="noreferrer noopener">Semiconductor ETFs Take A Beating, Dragged Lower By Nvidia, AMD, and Broadcom Stocks</a>
Wall Street is betting on a bounce-back in demand for mobile devices backed by Apple&#8217;s adoption of Wi-Fi 7 on the iPhone 16 and 16 Pro.
According to the Bloomberg report, analysts&nbsp;expect&nbsp;Taiwan Semiconductor&#8217;s revenue to grow 37% for the third quarter. Recently, Taiwan Semiconductor and Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) officials <a target="_blank" href="https://www.benzinga.com/government/24/09/40773084/taiwan-semiconductors-us-plant-matches-taiwan-production-yields-stock-gains" rel="noreferrer noopener">expressed optimism for</a> the AI industry.
Taiwan Semiconductor now earns&nbsp;more than 50% of its revenue from high-performance computing, a business segment driven by AI demand. The Nvidia supplier is also the leading manufacturer of the Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) iPhone&#8217;s central processor.&nbsp;
Production yield at the Arizona facility is <a target="_blank" href="https://www.benzinga.com/government/24/09/40773084/taiwan-semiconductors-us-plant-matches-taiwan-production-yields-stock-gains" rel="noreferrer noopener">reportedly at par</a> with that at its Taiwan facilities, signaling further optimism for the industry.
Taiwan Semiconductor stock has increased 82% in the last 12 months. Investors can gain exposure to the stock through the SPDR S&amp;P Emerging Asia Pacific ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMF#NYSE">GMF</a>) and the ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>).
Price Action:&nbsp;TSM stock traded lower by 0.80% to $161.52 premarket at the last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/m-a/24/09/40747080/intel-eyes-mobileye-stake-sale-amid-pressure-stock-slides" target="_blank" rel="noreferrer noopener">Intel Eyes Mobileye Stake Sale Amid Pressure, Stock Slides</a></li>
</ul>
Image via Shutterstock

Emerging Markets

Taiwan Semiconductor's Strong August Sales Hint at Big Gains Ahead, AI and iPhone Demand Fuel Optimism

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) stock is up Monday amid reports claiming that the contract chipmaker&#8217;s production yield at the Arizona facility is at par with its Taiwan facilities.
The Taiwanese chipmaker&#8217;s yield rate in trial production at its first advanced U.S. plant is similar to comparable facilities in the southern Taiwanese city of Tainan, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-06/tsmc-s-arizona-trials-put-plant-productivity-on-par-with-taiwan?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">cites</a> familiar sources.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/40754938/semiconductor-etfs-take-a-beating-dragged-lower-by-nvidia-amd-and-broadcom-stocks" rel="noreferrer noopener">Nvidia, AMD, and TSM Lead AI Stock Selloff, Dragging Semiconductor ETFs Down</a>
Recently, the Taiwan Semiconductor COO <a href="https://www.benzinga.com/news/24/09/40735058/taiwan-semis-supplier-dismisses-selloff-projects-strong-ai-growth-surge" target="_blank" rel="noreferrer noopener">expressed optimism for</a> the artificial intelligence industry. A Taiwan Semiconductor supplier, Scientech Corp, also made similar claims.
Taiwan Semiconductor and global partners also fast-tracked silicon photonics for AI, <a target="_blank" href="https://www.benzinga.com/news/24/09/40687807/whats-going-on-with-taiwan-semiconductor-stock-on-tuesday" rel="noreferrer noopener">implying continued demand</a>.
Taiwan Semiconductor postponed its Arizona plant production to 2025 from 2024 due to a need for more skilled workers. The contract chipmaker&#8217;s global expansion reflects attempts made by different countries to preserve their semiconductor base, which suffered immensely during the pandemic outbreak in China.
Taiwan Semiconductor stock has risen over 75% in the last 12 months. Investors can gain exposure to the stock through the SPDR S&amp;P Emerging Asia Pacific ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMF#NYSE">GMF</a>) and the ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>).
<h2 class="wp-block-heading">Is Taiwan Semiconductor A Good Stock To Buy?</h2>
Wall Street analysts view Taiwan Semiconductor on the whole as a Outperform, given the history of coverage over the past three months. Mark Li from Bernstein in Taiwan Semiconductor is the most optimistic, expecting a 33.33% rise in the stock in the coming year.
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past 3 months, Taiwan Semiconductor fell 9.54%, which indicates that opinion soured on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which rose 32.79% over the past year.
A complete overview of how Wall Street views individual stocks is available <a href="https://www.benzinga.com/analyst-stock-ratings">here</a>, while real time updates on the latest analyst actions will be delivered via <a href="https://pro.benzinga.com">Benzinga PRO</a>. Try it for free.
Price Action:&nbsp;TSM stock is up 2.00% at $159.96 premarket at the last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40692084/intels-place-in-dow-in-jeopardy-ai-strategy-under-scrutiny-report" target="_blank" rel="noreferrer noopener">Intel&#8217;s Place In Dow In Jeopardy, AI Strategy Under Scrutiny: Report</a></li>
</ul>
Photo by Jack Hong via Shutterstock

Taiwan Semiconductor's US Plant Matches Taiwan Production Yields, Stock Gains

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) supplier chief expressed conviction over artificial intelligence's potential to trigger the semiconductor industry's growth trajectory.
Scientech Corp CEO Hsu Ming-Chi expects sequential quarterly sales growth in the second half of 2024, backed by the demand surge for AI applications it makes for Taiwan Semiconductor to produce AI chips for Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Bloomberg Television <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-04/tsmc-supplier-s-ceo-dismisses-ai-concerns-after-nvidia-wipeout?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">cites</a> an interview.
In a way, Ming-Chi snubbed the current chip sector selloff led by Nvidia, which lost over 17% in the last five days. Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and Taiwan Semiconductor lost 6% during the period.
Nvidia's second-quarter print failed&nbsp;to impress the Street, triggering selloffs.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/05034522/newplot-1-2.png" alt="" class="wp-image-531149" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/05034522/newplot-1-2.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/05034522/newplot-1-2-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Ming-Chi hailed it as the beginning of the AI frenzy, citing a two—to three-fold annual growth in its equipment sales to Taiwan Semiconductor. He expects AI semiconductors to beat the global chip market growth of 8% in the last two decades.
Taiwan Semiconductor Co-COO Y.J. Mii <a href="https://www.benzinga.com/news/24/09/40711613/taiwan-semiconductor-bets-on-ai-growth-surge-samsung-joins-ai-optimism-in-trade-show" target="_blank" rel="noreferrer noopener">made similar claims</a> at the Semicon Taiwan industry forum in Taipei this Wednesday, projecting a 50% compound growth rate for AI accelerator. Samsung Electronics' memory chip business President, Lee Jung-Bae, backed Mii&#8217;s projection at the event.
<a target="_blank" href="https://www.benzinga.com/news/24/09/40687807/whats-going-on-with-taiwan-semiconductor-stock-on-tuesday" rel="noreferrer noopener">Recent reports claimed</a> Taiwan Semiconductor and its partners are fast-tracking silicon photonics for AI, targeting a $500 million market by 2028.
Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) supplier Hon Hai Precision Industry Co, also known as Foxconn reported a 33% month-over-month topline growth in August 2024, bearing testimony to the continued AI frenzy.
The results reflect a recovery from a smartphone slump, backed by demand for AI servers containing&nbsp;Nvidia's AI accelerators, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-05/iphone-maker-hon-hai-s-august-sales-climb-33-on-ai-demand?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">reports</a>.
Taiwan Semiconductor stock has risen over 70% in the last 12 months. Investors can gain exposure to the stock through the SPDR S&amp;P Emerging Asia Pacific ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMF#NYSE">GMF</a>) and the ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>).
Price Action: TSM stock is trading higher by 1.63% at $163.50 at the last check on Thursday.
Photo by Jack Hong via Shutterstock

Taiwan Semi's Supplier Dismisses Selloff, Projects Strong AI Growth Surge

Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) shares are trading higher after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40494008/agilent-reports-third-quarter-fiscal-year-2024-financial-results" rel="noreferrer noopener">reported third-quarter results yesterday</a>.
Revenue fell 5.6% Y/Y to $1.58 billion, beating the consensus of $1.56 billion. By segment, the Life Sciences and Applied Markets Group (LSAG) segment reported revenue of $782 million, down 8% Y/Y (-7% Y/Y core), with an operating margin of 28.4%.
The Agilent CrossLab Group (ACG) revenue came in at $411 million, up 4% Y/Y (+5% Y/Y core), with an operating margin of 34.0%.
The Diagnostics and Genomics Group (DGG) revenue stood at $385 million, down 9% Y/Y (-8% Y/Y core), with an operating margin of 18.3%.
As of July 31, cash and cash equivalents stood at $1.78 billion. Adjusted EPS of $1.32 surpassed<a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener"> the street view of $1.26</a>.
Outlook: Agilent forecasts fourth-quarter revenue of $1.641 billion &#8211; $1.691 billion (vs. $1.67 billion estimate) and adjusted EPS of $1.38 &#8211; $1.42 (vs. street view of $1.44).
For FY24, Agilent revised its revenue outlook to $6.45 billion &#8211; $6.5 billion from $6.42 billion &#8211; $6.5 billion (vs. $6.46 billion estimate) and adjusted EPS to $5.21 &#8211; $5.25 (vs. $5.20 estimate) <a target="_blank" href="https://www.benzinga.com/news/earnings/24/05/39075050/agilent-technologies-stock-sinks-after-company-cuts-guidance-to-reflect-slower-market-recovery" rel="noreferrer noopener">from $5.15 &#8211; $5.25 earlier</a>.
Agilent President and CEO Padraig McDonnell said, &#8220;While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated. We continue to make investments in our most promising growth opportunities.&#8221;
&#8220;And we are mobilizing the organization to accelerate value creation through strategic transformation initiatives, which will drive margin expansion and growth—and increase our execution capabilities.&#8221;
Investors can gain exposure to the stock via&nbsp;ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>) and VanEck ETF Trust VanEck Morningstar Wide Moat Growth ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/MGRO#BATS">MGRO</a>).
Price Action: A shares are up 1.88% at $142.63 at the last check Thursday.
Image from Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40503213" target="_blank" rel="noreferrer noopener">EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Earnings

Large Cap

Guidance

MGRO

Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off

The U.S. Food and Drug Administration (FDA) may approve <a href="http://Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows">updated COVID-19 vaccines</a> this week to combat recent strains as the country endures its most significant summer outbreak in two years.
The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) and Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), which is collaborating with BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>), to fight a COVID strain called KP.2, CNN <a href="https://www.cnn.com/2024/08/16/health/fda-updated-covid-19-vaccines/index.html">reported</a> Sunday. 
It was uncertain whether the agency would approve Novovax, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) most recent vaccine for COVID&#8217;s JN.1 strain at the same time, the report said. 
Representatives for Pfizer and Moderna told CNN they have plenty of updated COVID vaccines ready for shipment to stores upon approval.
Novovax executives said in a conference call last week that the company&#8217;s updated vaccine would arrive in warehouses for distribution some time this month because its vaccine is based on protein technology and therefore takes longer to make.
Read Also: <a href="https://www.benzinga.com/general/biotech/24/07/39847869/covid-activity-is-elevated-across-26-states-in-summer-surge-biden-remains-in-isolation-3-vaccine-">COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch</a>
Summer COVID Wave: Levels of the SARS-CoV-2 virus, COVID-19&#8217;s cause, measured in wastewater are at "very high" levels across the U.S., Centers for Disease Control and Prevention data shows. 
COVID waves result from waning immunity and new variants, according to experts. According to CDC data, the KP.3.1.1 strain accounts for 37% of cases over the last two weeks, tripling from a month ago.
KP.3.1.1 and KP.2 are both JN.1 offshoots, and all three are&nbsp;versions of the Omicron variant.
As of Aug. 13, COVID-19 infections are growing or likely growing in 25 states, declining or likely declining in five states and are stable or uncertain in 17 states, <a href="https://www.cdc.gov/cfa-modeling-and-forecasting/rt-estimates/index.html">according</a> to CDC data.
States where infections are growing include Alabama, North Dakota, South Dakota, Georgia, Kentucky, Massachusetts, New Hampshire, Vermont and Virginia.
Price Action: Moderna, Pfizer and Novovax made gains into Monday&#8217;s late-morning trading, while most of the exchange-traded funds that track them also trended upward.
ETFs with Moderna, which gained 1.72% to $88.33.
<ul>
<li>Langar Global HealthTech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGHT#NYSE">LGHT</a>) ticked up 0.37%</li>
<li>Amplify Treatments, Testing and Advancements ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GERM#NYSE">GERM</a>) declined 1.13%</li>
<li>Invesco Nasdaq Biotechnology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBBQ#NASDAQ">IBBQ</a>) edged up 1.28%</li>
</ul>
ETFs with Pfizer, which rose 1.55% to $28.74.
<ul>
<li>First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXH#NASDAQ">FTXH</a>) went up 1.19%</li>
<li>First Trust Morningstar Dividend Leaders Index Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDL#NYSE">FDL</a>) gained 0.73%</li>
<li>Invesco Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJP#NYSE">PJP</a>) rose 0.10%</li>
</ul>
ETFs with Novovax, which shot up 5.98% to $13.73.
<ul>
<li>ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>) slipped 0.62%</li>
<li>iShares Genomics Immunology and Healthcare ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDNA#NYSE">IDNA</a>) rose 0.89%</li>
<li>Virtus LifeSci Biotech Products ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBP#NYSE">BBP</a>) remained unchanged</li>
</ul>
Read Next:
<ul>
<li><a href="https://feeds2.benzinga.com/news/24/01/36635307/anthony-faucis-ex-boss-now-admits-covid-19-lab-leak-theory-is-credible-and-not-a-conspiracy">Anthony Fauci&#8217;s Ex-Boss Now Admits COVID-19 Lab Leak Theory Is Credible And &#8216;Not A Conspiracy&#8217;</a></li>
</ul>
Photo: Unsplash

Trading Ideas

ETFs

BNTX

First Trust Morningstar Dividend Leaders Index Fund

FTXH

ETFMG Treatments Testing and Advancements ETF

GERM

IBBQ

IDNA

LGHT

MRNA

NVAX

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch

Coherent Corp.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) shares are trading higher after the Board of Directors has appointed Jim Anderson <a target="_blank" href="https://www.benzinga.com/pressreleases/24/06/g39134653/coherent-appoints-jim-anderson-as-chief-executive-officer" rel="noreferrer noopener">as the new Chief Executive Officer, effective today</a>.
Anderson is succeeding Vincent D. Mattera, Jr., who, as previously announced, is <a target="_blank" href="https://www.benzinga.com//node/37210571" rel="noreferrer noopener">retiring as Chair and CEO of Coherent</a>.
Anderson joined Coherent from Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>), where he served as President, Chief Executive Officer, and a member of its Board of Directors. Lattice Semiconductor&#8217;s <a href="https://www.benzinga.com//node/39140142" target="_blank" rel="noreferrer noopener">stock plunged following Anderson&#8217;s departure.</a>
Prior to joining Lattice in 2018, Anderson was senior vice president and general manager of Advanced Micro Devices, Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) Computing and Graphics business group.&nbsp;
He previously held leadership positions in general management, engineering, sales, marketing, and strategy at several companies.
Anderson holds an MBA and Master of Science in electrical engineering and computer science from the Massachusetts Institute of Technology, a Master of Science in electrical engineering from Purdue University, and a Bachelor&#8217;s degree in electrical engineering from the University of Minnesota.
Enrico DiGirolamo, Board Chair, said, &#8220;Jim&#8217;s business acumen and technical capability, coupled with his extensive experience transforming complex global businesses to deliver above-market growth and profitability, make him the ideal leader to steer Coherent through its next chapter amidst a rapidly changing market.&#8221;&nbsp;&nbsp;
&#8220;I am confident that Coherent will benefit from Jim&#8217;s operational expertise, innovation-first approach, and in-depth knowledge of our market and platform, as we capitalize on the strong market demand we see across our AI-related datacom portfolio and improving industrial market, while leveraging our diversification strategy that continues to serve us well.&#8221;
Last month, Coherent launched next-generation high-power laser sensor, which is designed to support the expanding high-power applications market and can reduce <a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/g39080433/coherent-introduces-high-power-laser-sensor" rel="noreferrer noopener">measurement times by up to 500%</a>.
Investors can gain exposure to the stock via ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>) and SPDR S&amp;P Kensho Final Frontiers ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROKT#NYSE">ROKT</a>).
Price Action: COHR shares are up 18.3% at $67.52 at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Management

LSCC

ROKT

Why Coherent Shares Are Seeing Blue Skies Today

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) is gearing up for increased demand for AI-capable consumer products. It anticipates that businesses will increasingly rely on private environments for AI computing needs.
Intel aims to integrate AI capabilities across various products, from computers to edge computing to software, the Wall Street Journal <a target="_blank" href="https://www.wsj.com/tech/intel-betting-on-ai-well-beyond-data-centers-18c31f42?mod=tech_lead_story" rel="noreferrer noopener">cited</a> Alexis Crowell, Intel&#8217;s VP and CTO for Asia-Pacific and Japan.
Crowell noted that demand for traditional data centers might slow as companies seek a balance between public cloud infrastructure and private data storage for privacy and cost reasons.
This shift aligns with IDC&#8217;s prediction that by next year, 75% of enterprise-generated data will be processed outside traditional data centers or the cloud.
Intel, traditionally strong in CPUs for personal computers and servers, faces challenges in the data center market dominated by Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) AI chips.
Despite this, Intel&#8217;s data center and AI division saw a 5% revenue increase to $3 billion in Q1.
The company plans to bolster its AI chip offerings with the Gaudi 3 chip, which will likely outperform Nvidia&#8217;s H100 and generate $500 million in revenue in the latter half of 2024, WSJ writes.
Chip company CEOs, including Intel and Nvidia, have gathered at&nbsp;Taiwan&#8217;s Computex event to <a target="_blank" href="https://www.benzinga.com/news/24/05/39102792/nvidia-ceo-jensen-huang-along-with-amd-arm-intel-bosses-will-converge-at-taiwans-ai-tech-fest-event" rel="noreferrer noopener">discuss AI&#8217;s prospects</a>.
<a target="_blank" href="https://www.benzinga.com/markets/equities/24/05/38991539/nvidias-ai-dominance-leaves-intel-amd-scrambling-for-second-place" rel="noreferrer noopener">Currently, Intel and</a> Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) are battling for the AI PC market&#8217;s dominance, while Nvidia sealed its numero uno position with its latest quarterly earnings beat.
Intel has&nbsp;earmarked shipping chips&nbsp;for over 100 million AI PCs by 2025, including over 40 million in 2024.&nbsp;
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31102140/newplot-42.png" alt="" class="wp-image-365552" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31102140/newplot-42.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31102140/newplot-42-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Intel stock lost over 4% in the last 12 months. Investors can gain exposure to the stock via ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>)
and First Trust S-Network Streaming And Gaming ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNGE#NYSE">BNGE</a>).
Price Action: INTC shares traded lower by 0.63% at $30.00 at the last check on Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

BNGE

INTC

Intel Eyes Increased AI Product Demand, Shifts Focus to Private Data Storage Solutions

Benchmark&nbsp;analyst Mark Miller maintained&nbsp;ACM Research Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) with a Buy and raised the&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/ACMR/analyst-ratings" rel="noreferrer noopener">price target from $35 to $38</a>. The stock price climbed after the re-rating.
Miller noted several factors contributing to double-digit growth in 2025 for ACM Research.
The factors included strong DRAM demand driven by HBM opportunities, a recovery in NAND demand, $100 billion in combined funding by the U.S., Europe, and Japan for internal chip production, geographic expansion of demand, share gains, and new products.&nbsp;&nbsp;
As per the analyst, R&amp;D spending for 2024 will likely represent 16% of sales, while sales and marketing are estimated to represent 7%-8% of sales.&nbsp;
The analyst said that general and administrative expenses will likely represent 5%-8% of sales.&nbsp;&nbsp;
For 2025, Miller projects an adjusted EPS of $2.11 on sales of $860 million. This represents 54% top-line and 29% percent bottom-line growth from 2023.&nbsp;
In February, ACM Research reported&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/02/37363861/why-is-acm-research-stock-soaring-wednesday" rel="noreferrer noopener">fourth-quarter fiscal 2023</a>&nbsp;revenues of $170.3 million, up by 56.9% Y/Y, beating the analyst consensus of $149.3 million.&nbsp;
ACMR reported an adjusted EPS of $0.43, beating the street view of $0.17.
Investors can gain exposure to the stock via&nbsp;Matthews China Discovery Active ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHS#NASDAQ">MCHS</a>) and&nbsp;ProShares Nanotechnology ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>).
Price Action: ACMR shares are trading higher by 5.45% to $30.81 on the last check Wednesday.
Photo via Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

ACMR

MCHS

ACM Research Predicted To Achieve Double-Digit Growth in 2025 Due to Expanding Chip Demand: Analyst

Harris & Harris Group Reports FY16 Increase In Net Assets/Share $0.53 vs $0.65 In Same Qtr. Last Year, Total Investment Income $1.792M vs $0.916M YoY

Hedge Funds

Financial & Investment Management Group Reports 5.75% Stake In Harris & Harris Group

Harris & Harris Shares to Resume Trade at 5 p.m. EST

UPDATE: Harris & Harris Says Has Developed Proposal to Split Into Two Entities: 180 Degree Capital, HALE.life Corp

FOURTH QUARTER UPDATE 2016
Fellow Shareholders:
The purpose of this letter is to share with you a proposed plan for a strategic restructuring that we believe has the opportunity to unlock value for our shareholders. Specifically, we are recommending the separation of Harris &amp; Harris Group, currently a business development company ("BDC"), into two distinct entities. The first entity will be a registered closed-end fund named 180 Degree Capital Corp ("180") that will focus on (1) optimizing the value in our existing portfolio; and (2) pursuing a new investment strategy focused on constructive activism in substantially undervalued small, publicly traded companies. The second entity, HALE.life Corp ("HALE"), will be an operating company focused exclusively on building a high-growth, precision health and medicine business. 
On November 14, 2016, we published our Third Quarter Letter to Shareholders. In this letter, we noted that it is time for Harris &amp; Harris Group to change. We stated that, "we continue to have companies in our portfolio that we believe are performing well…. We believe these companies have the potential to generate investment returns that are meaningful, and potentially larger than our historical returns." That said, we can no longer accept that our stock price reflects the inability by the market to price the potential of our portfolio of venture capital investments. We also believe the market reflects a pessimistic view of our business model.
For the past several quarters, Management and the Board of Directors, with significant input from outside accounting firms and legal counsel, have been working on a long-term plan that provides the following benefits to shareholders:
1) A reduction of the expenses borne by our shareholders while maintaining the value in our existing portfolio; and
2) Repositioning the company to maximize future value for shareholders. 
We developed a proposal to split into two entities following careful assessment of a number of potential strategic alternatives during the prior two years. These alternative paths did not provide what we believe would be adequate value for our shareholders. In fact, we believe most compromised the potential future growth in value should holdings from our current portfolio appreciate significantly. 
180 Degree Capital Corp
We propose to manage the assets that are not core to the business strategy of HALE under the name 180 Degree Capital Corp ("180"). Our proposal will include steps to enable 180 to be operated as an internally managed, non-diversified registered closed-end fund rather than electing to be regulated as a BDC under the 1940 Act, because of the lower expense and regulatory burden we believe will be imposed on 180 in a closed-end fund structure. Specifically, we believe that the BDC-related direct costs are far higher than the cost of managing the same assets in a registered closed-end fund structure. We chose the name 180 Degree Capital Corp because the name embodies our go-forward investment strategy. 
180 will be led by Kevin Rendino, a current member of our Board of Directors, as CEO, and by Daniel Wolfe, our current President, CFO and CCO, who will serve in those same roles for 180. Initially, 180 will be focused on shepherding the existing portfolio of investments to maximize returns, with what we believe will be less regulatory burden and expense to shareholders than in a BDC structure. 180's future business will be focused on making decisions that are designed to generate income and grow net asset value per share for shareholders over shorter, more predictable timeframes. Toward this goal, 180 will focus on investing in and providing value-add assistance through constructive activism to what 180's management team believes are substantially undervalued small, publicly traded companies that have potential for aggressive growth. Our goal is that the result of our constructive activism leads to a reversal in direction for the share prices of these investee companies, i.e., a 180-degree turn.
Kevin Rendino, a financial services leader with three decades of Wall Street experience, joined Harris &amp; Harris Group's Board of Directors in 2016. We believe his significant expertise in capital markets, value investing and global equity markets will enable 180 to identify and thoroughly evaluate potential investment opportunities. For over twenty years, Mr. Rendino worked on one fund, Basic Value Fund, with a consistent focus over that time frame. He was ultimately the lead portfolio manager for the Basic Value Fund and oversaw 11 funds representing approximately $13 billion in total assets. Mr. Rendino was also a member of Blackrock's Leadership Committee. Since 2012, Mr. Rendino has served as Chairman and CEO of RGJ Capital, where he leads a value investing approach. 
We believe 180 combines new perspectives with the historical knowledge and experience of managing the current portfolio. We believe these complementary sets of experiences and skills in investment management and in working with management teams to build businesses can be a foundation for future growth. We believe 180 will be able to generate income and grow net asset value per share for shareholders over shorter, more predictable timeframes than those we have experienced over the past several years.
While there are multiple fund managers that invest in smaller publicly traded companies, we believe that these managers are often not able or interested to engage with such companies on an active basis. We believe 180's expertise and focus on constructive activism could be an attractive complement to other investors in the space. Our new simplified structure and focus could lead to partnerships or other opportunities. We believe that the universe of potential partners on this strategy is substantially larger than those focused on privately held investments. We believe we will be in a strong position to seek these strategic partnership opportunities with the current and future assets of 180.
HALE.life Corp
Concurrent with the steps to enable 180 to be operated as an internally managed, non-diversified registered closed-end fund, we will also take steps to manage the assets that comprise HALE as an operating company. This will substantially lower our cost of business. This operating company will deliver products that change how physicians provide and patients receive healthcare. HALE will retain certain of our precision health and medicine investments, most of which represent control positions. Doug Jamison, our current Chairman and CEO, will lead HALE.life as CEO. 
After building companies over many years primarily as minority shareholders, we believe it is time to return to our roots building transformative companies that we control in an operating company structure. 
We believe patients now expect more communication, better outcomes and care that are specific to their needs. Patients and physicians are increasingly demanding access to the latest and best actionable health information based on the individual characteristics of the patient. Examples include genetic sequencing, metabolic profiles and composition of the gut microbiome, which are often referred to as precision medicine information. Currently, it is expensive and difficult for physicians and patients to access, understand and provide the desired, tailored information for individual lifestyles or illnesses. Technologies, both diagnostic and mobile, are ready to solve these problems, but they have yet to be assembled into a complete solution. 
HALE will be seeking to transform the $250 billion primary care clinical market. Many traditional businesses such as the hotel industry, retail sales, and automobile sales have undergone tremendous change driven by consumers' increasing power resulting from expanded access to information. We believe healthcare is about to undergo this similar change. 
HALE addresses these issues by seeking to change how physicians provide and patients receive healthcare. HALE accomplishes this by linking next-generation, precision medicine products to the growing popularity of functional and integrative medicine practices. HALE will provide physicians in these practices with what we believe is actionable information derived from analyzing advanced, precision medicine technologies. Physicians and patients will receive user-friendly reports providing personalized, empirically based care options. Physicians and patients can then use their time together to collaborate on care. Patients serviced by this business model include those interested in performance sports, wellness, longevity and the care of chronic diseases. 
Functional and integrative medicine clinics have been growing rapidly over the last decade as patients have turned to these alternative practices for more personalized treatment for chronic diseases and for prolonging health. There are currently over 10,000 physicians who are practicing in functional and integrative medicine clinics or under similar new business models in the United States and by some measures these practices are growing over 30 percent per year. Precision medicine technologies such as genetic sequencing, metabolomics, microbiomics, new imaging technologies and data analytics have also been developing over this same decade. We believe the uniqueness of our approach is that we link the growing interest by patients in these new personalized, functional and integrative medicine practices with the management systems and advanced information tools these clinics require to perform empirical and predictive medicine. We believe this new model provides a total care solution to physicians and patients.
HALE aims to increase value for its shareholders by focusing on ongoing operations, rather than acting as an investment company. Revenue growth and net income growth over time will be its metrics of success. Through its controlled companies, we believe HALE has assembled the component companies necessary to execute its proposed business plan. 
Summary and Next Steps
We believe separating the entities accomplishes four primary tasks that we believe are beneficial to shareholders: 
1) we believe it presents the best opportunity to increase shareholder value; 
2) it optimizes expense, structure and management focus; 
3) it permits the ability to focus each business on strategies for future value creation without conflicts or distractions; and 
4) it permits the clear messaging of shorter- and longer-term strategies for shareholders. 
As separate entities, we believe that HALE and 180 will be ultimately valued based on execution of their focused strategies with what we believe will be a higher potential to unlock value in the market. Each company will develop separately and communicate its respective business story, financial performance and investment rationale. 
We currently aim to implement this restructuring during the second quarter of 2017. In connection with the restructuring, we will ask shareholders for approval, as required by applicable laws and regulations, to take certain steps necessary to position both entities for potential future success. The restructuring will be discussed in detail in proxy materials that we currently expect to file in early 2017.
In our November 14, 2016, Letter to Shareholders, we stated that "in early January 2017, we will be organizing a shareholder call to discuss the proposed changes we will seek to implement as part of the long-term plan being developed by management and our Board of Directors." This call is currently scheduled for Tuesday, January 10, 2017, at 2:00pm Eastern Time. The dial-in information for the call is noted below:
U.S. Domestic Dial-In Number: (641) 715-0632
International Dial-In Numbers: please see <a href="http://www.hhvc.com/wp-content/uploads/2016/12/International-Dial-In-Numbers.pdf" title="http://www.hhvc.com/wp-content/uploads/2016/12/International-Dial-In-Numbers.pdf">http://www.hhvc.com/wp-content/uploads/2016/12/International-Dial-In-Numbers.pdf</a>
Passcode: 415049
This Letter will serve as the background for that discussion. Over the coming months, we will provide more details on the proposed restructuring, its expected timing, and how 180 and HALE will work to build shareholder value. We are excited about the potential opportunities for our shareholders and look forward to speaking with you on Tuesday, January 10, 2017.
Sincerely,
Douglas W. Jamison 
Chairman &amp; Chief Executive Officer
Richard P. Shanley 
Lead Independent Director

Press Releases

Harris & Harris Group Announces a Proposed Strategic Restructuring

Harris & Harris Shares Halted News Pending

Harris & Harris Group Shares Tick Higher as Co. Announces Its Portfolio Co., Mersana Therapeutics, Has Received FDA Clearance of IND App for XMT-1522

Harris & Harris Reports NAV Of $81.284M And $2.63 NAV/Share

Insider Trades

Director Rendino Buys 34,053 Shares of Harris & Harris @$1.66/Share -Form 4

Comments

ProShares Nanotechnology ETF

Notizie

Ultime notizie per ProShares Nanotechnology ETF (ARCA:TINY)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO